What this study is
The purpose of the Registry study is to observe the improvement in subject-reported clinical outcomes for percutaneous orthopedic procedures for treatment of musculoskeletal disorders.
What's being tested
- Orthobiologic Procedures
Intervention · PROCEDURE
To observe the improvement in subject-reported clinical outcomes for percutaneous orthopedic procedures used to treat musculoskeletal disorders.
Study details
- Official title
- Interventional Orthopedics Foundation Patient Registry Database-A Clinical Registry of Orthobiologics Procedures
- Sponsor
- Regenexx, LLC
- Conditions
- Orthopedic Disorder
- Enrolling
- 50,000 people
- Starts
- 2016-02
- Est. completion
- 2036-02
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Voluntary signature of the IRB approved Informed Consents,
- Treated with a Regenexx procedure
- Have a musculoskeletal condition appropriate for the procedure such as osteoarthritis or internal joint derangement; ligament or tendon injury; intervertebral disc degeneration; protrusion, extrusion, or annular tear; muscle tear
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (32)
32 openCatalyst Pain Solutions
Phoenix, Arizona, United States
Healthlink Center
Beverly Hills, California, United States
Healthlink Center
Oceanside, California, United States
Healthlink Center
San Rafael, California, United States
Southern California Orthopedic Institute
Thousand Oaks, California, United States
Southern California Orthopedic Institute-Van Nuys
Van Nuys, California, United States
Centeno-Schultz Clinic
Broomfield, Colorado, United States
Regenexx
Broomfield, Colorado, United States
New reGeneration Orthopedics
Sarasota, Florida, United States
Chicago Arthritis
Chicago, Illinois, United States
Orthopedic Stem Cell Resource
Des Plaines, Illinois, United States
Harbor View Medical
Des Moines, Iowa, United States
Bodyworks Musculoskeletal Medicine
Louisville, Kentucky, United States
Total Care-LA
Lafayette, Louisiana, United States
Stem Cell ARTS-MD
Chevy Chase, Maryland, United States
RejuvMedical
Waite Park, Minnesota, United States
New Jersey Sports Medicine
Cedar Knolls, New Jersey, United States
Orthopedic Stem Cell Solutions
Oakhurst, New Jersey, United States
Rehabilitation Center of New Jersey
Wayne, New Jersey, United States
Rehabilitation Center of New York
New York, New York, United States
Beacon Orthopaedics
Cincinnati, Ohio, United States
ProMedica
Toledo, Ohio, United States
RegenOrthoSport
Tulsa, Oklahoma, United States
Columbia Pain Management
Hood River, Oregon, United States
Rehabilitation and Pain Specialists
Pittsburgh, Pennsylvania, United States
Center for Sports Medicine
Springfield, Pennsylvania, United States
RegenOrthoSport
Dallas, Texas, United States
Wasatch Pain Solutions
South Jordan, Utah, United States
Vermont Regenerative Medicine
Winooski, Vermont, United States
Stem Cell ARTS-VA
McLean, Virginia, United States
2 sites outside the US
Nepean Specialist Sports Medicine
Kingswood, New South Wales, Australia
RegenOrthoSport
Hyderabad, Telangana, India
Study team
Sponsor
Regenexx, LLC
Study ID RSI2015-REG01
Principal investigator
Christopher Centeno, MD
Regenerative Sciences, LLC and Centeno-Schultz Clinic
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.